These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20726797)

  • 21. FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma.
    Zhu XL; Zeng YF; Guan J; Li YF; Deng YJ; Bian XW; Ding YQ; Liang L
    J Pathol; 2011 Jul; 224(3):377-88. PubMed ID: 21506128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.
    Kasashima H; Duran A; Martinez-Ordoñez A; Nakanishi Y; Kinoshita H; Linares JF; Reina-Campos M; Kudo Y; L'Hermitte A; Yashiro M; Ohira M; Bao F; Tauriello DVF; Batlle E; Diaz-Meco MT; Moscat J
    Dev Cell; 2021 Jan; 56(1):95-110.e10. PubMed ID: 33207226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
    Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressor functions of miR-133a in colorectal cancer.
    Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
    Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the embryonic protein SOX2 in cholangiocarcinoma.
    Sun Q; Li J; Wang G; Xie Y
    Cell Biochem Biophys; 2014 Nov; 70(2):1311-6. PubMed ID: 24906237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways.
    Duan L; Wu R; Zou Z; Wang H; Ye L; Li H; Yuan S; Li X; Zha H; Sun H; Zhang Y; Chen X; Zhou L
    Int J Oncol; 2014 Mar; 44(3):781-90. PubMed ID: 24378749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer.
    Chou YT; Lee CC; Hsiao SH; Lin SE; Lin SC; Chung CH; Chung CH; Kao YR; Wang YH; Chen CT; Wei YH; Wu CW
    Stem Cells; 2013 Dec; 31(12):2607-19. PubMed ID: 23940081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis.
    Fang X; Yoon JG; Li L; Yu W; Shao J; Hua D; Zheng S; Hood L; Goodlett DR; Foltz G; Lin B
    BMC Genomics; 2011 Jan; 12():11. PubMed ID: 21211035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
    Li X; Liang L; Huang L; Ma X; Li D; Cai S
    Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J; Kou YB; Zhu JS; Chen WX; Li S
    Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
    Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ANGPTL1 attenuates cancer migration, invasion, and stemness through regulating FOXO3a-mediated SOX2 expression in colorectal cancer.
    Chang TY; Lan KC; Chiu CY; Sheu ML; Liu SH
    Clin Sci (Lond); 2022 May; 136(9):657-673. PubMed ID: 35475476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway.
    Huang C; Lu H; Li J; Xie X; Fan L; Wang D; Tan W; Wang Y; Lin Z; Yao T
    Gynecol Oncol; 2018 Dec; 151(3):533-541. PubMed ID: 30336948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.